AU2003243243A1 - Methods to detect, isolate, target and manipulate hiv-infected t cells - Google Patents

Methods to detect, isolate, target and manipulate hiv-infected t cells

Info

Publication number
AU2003243243A1
AU2003243243A1 AU2003243243A AU2003243243A AU2003243243A1 AU 2003243243 A1 AU2003243243 A1 AU 2003243243A1 AU 2003243243 A AU2003243243 A AU 2003243243A AU 2003243243 A AU2003243243 A AU 2003243243A AU 2003243243 A1 AU2003243243 A1 AU 2003243243A1
Authority
AU
Australia
Prior art keywords
hiv
infected
manipulate
isolate
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003243243A
Inventor
Alex Franzusoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Colorado
Original Assignee
University of Colorado
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Colorado filed Critical University of Colorado
Publication of AU2003243243A1 publication Critical patent/AU2003243243A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2003243243A 2002-05-15 2003-05-15 Methods to detect, isolate, target and manipulate hiv-infected t cells Abandoned AU2003243243A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38098702P 2002-05-15 2002-05-15
US60/380,987 2002-05-15
PCT/US2003/015371 WO2003097088A2 (en) 2002-05-15 2003-05-15 Methods to detect, isolate, target and manipulate hiv-infected t cells

Publications (1)

Publication Number Publication Date
AU2003243243A1 true AU2003243243A1 (en) 2003-12-02

Family

ID=29550046

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003243243A Abandoned AU2003243243A1 (en) 2002-05-15 2003-05-15 Methods to detect, isolate, target and manipulate hiv-infected t cells

Country Status (2)

Country Link
AU (1) AU2003243243A1 (en)
WO (1) WO2003097088A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1825317B1 (en) * 2004-11-24 2013-04-17 Battelle Memorial Institute Optical system for cell imaging

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851795A (en) * 1991-06-27 1998-12-22 Bristol-Myers Squibb Company Soluble CTLA4 molecules and uses thereof

Also Published As

Publication number Publication date
WO2003097088A2 (en) 2003-11-27
WO2003097088A3 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
AU2003256703A1 (en) Biosensor arrays and methods
AU2003238796A1 (en) Methods and apparati using single polymer analysis
AU2003252586A1 (en) Individual cryptoprotective complex
AU2003247514A1 (en) Meningeal-derived stem cells
AU2003251898A1 (en) Device and methods for isolating target cells
AU2003268457A1 (en) Biomap analysis
AU2003295122A1 (en) Sample vessel
AU2003216822A1 (en) Stem cell culture
AU2003209466A1 (en) Detection system
AU2003251374A1 (en) Analysis system
WO2005110009A8 (en) COMPOSITIONS AND METHODS RELATING TO TSP-30a, b, c AND d
AU2003269339A1 (en) Very large vessel construction
AU2003276973A1 (en) Detection methods
AU2003295745A1 (en) Polynucleotide sequence detection assays
AU2003250710A1 (en) Sampling method
AU2002353367A1 (en) Antiulcer herbal composition(s)
AU2003234210A1 (en) Direct cell target analysis
AU2003217565A1 (en) Polydioxaborines, their monomers and their preparation
AU2003273349A1 (en) Devices and methods for isolating and recovering target cells
AU2003279967A1 (en) Photoelectric cell
AU2003277444A1 (en) Two-way ranging techniques
AU2003243243A1 (en) Methods to detect, isolate, target and manipulate hiv-infected t cells
AU2003302077A1 (en) Freeze concentration system
AU2003258990A1 (en) Sensitizer-labeled analyte detection
AU2002368386A1 (en) Peer to peer electronic-payment system

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase